Diversify Advisory Services’s Arcturus Therapeutics ARCT Stock Holding History

Diversify Advisory Services’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90.9K	Buy	+15,785	New	+$124K	﹤0.01%	1226
2026 Q1	–	Sell	-15,000	Closed	-$109K	–	247
2025 Q4	$109K	Hold	15,000	–	–	﹤0.01%	896
2025 Q3	$140K	Sell	15,000 -207,500	-93%	-$3.33M	﹤0.01%	853
2025 Q2	$3.31M	Buy	222,500 +204,500	+1,136%	+$2.42M	0.13%	119
2025 Q1	$231K	Buy	+18,000	New	+$286K	0.01%	575

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Diversify Advisory Services's ARCT Position: Q2 2026 in Review

Diversify Advisory Services opened a new position in Arcturus Therapeutics (ARCT) in Q2 2026: 15,785 shares worth $90.9K. The stake represents ﹤0.01% of the portfolio and ranks #1226 among its holdings. This is a return to the name: Diversify Advisory Services previously reported a position in ARCT as recently as Q4 2025.

Diversify Advisory Services first reported a position in ARCT in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.31M in Q2 2025. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

Diversify Advisory Services held 15,785 shares of Arcturus Therapeutics worth $90.9K as of Q2 2026.
Arcturus Therapeutics was a new Diversify Advisory Services position in Q2 2026.
Arcturus Therapeutics made up ﹤0.01% of Diversify Advisory Services's portfolio in Q2 2026, its #1226 holding.
Diversify Advisory Services first reported a position in Arcturus Therapeutics in Q1 2025 and has held it in 5 quarters since.
Diversify Advisory Services's Arcturus Therapeutics position peaked at $3.31M in Q2 2025.
135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.